Search results
Results From The WOW.Com Content Network
ZyCoV-D is a DNA plasmid-based COVID-19 vaccine developed by Indian pharmaceutical company Cadila Healthcare, with support from the Biotechnology Industry Research Assistance Council. It is approved for emergency use in India.
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. [ 4 ] [ 5 ] The company's product portfolio includes prescription medicines and vaccines .
In April 2021, the Drugs Controller General of India permitted the vaccine candidate to start phase III clinical trials. A total of 1,268 healthy participants between the age of 18 and 80 years to be selected from 15 sites across India for the trial and intended to be part of a larger global Phase III study.
On 12 April, the DCGI approved Russia's Sputnik V vaccine for emergency use in India. A phase 3 trial was conducted in the country in September 2020, which showed 91.6% efficacy. [44] The local distributor Dr. Reddy's Laboratories stated that it planned to have the vaccine in India by late May 2021. [45]
In April 2021, the Indian Council of Medical Research reported that the vaccine has shown promising results in neutralising lineage B.1.617. [54] [55] In May 2021, a joint investigation by the scientists of the National Institute of Virology, found the vaccine effective in neutralising the Zeta variant or lineage P.2 (previously known as B.1.1. ...
National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) is an expert committee constituted by the Ministry of Health and Family Welfare (MoHFW), India to provide advice and guidance on all aspects of COVID-19 vaccination.
Vaccine Maitri ("Vaccine Friendship") [1] is a humanitarian initiative undertaken by the Indian government to provide COVID-19 vaccines to countries around the world. [2] The government started providing vaccines from 20 January 2021. As of 21 February 2022, India had delivered around 16.29 crore (162.9 million) doses of vaccines to 96 ...
The Sanofi–GSK COVID-19 vaccine, sold under the brand name VidPrevtyn Beta, is a COVID-19 vaccine developed by Sanofi Pasteur and GSK. [ 4 ] [ 5 ] The Sanofi–GSK COVID‑19 vaccine was approved for medical use in the European Union in November 2022.